Rivaroxaban to prevent complications of portal hypertension in cirrhosis: The CIRROXABAN study

Journal:

Journal of Hepatology

Published:

2025-07-20

DOI:

10.1016/j.jhep.2025.06.035

Affiliations:

22

Authors:

37

Go to article

Institutions	Authors	Share
Biomedical Research Networking Center in Hepatic and Digestive Diseases (CIBEREHD), Spain	6.666667	0.18
Instituto de Investigación Marqués de Valdecilla (IDIVAL), HUMV, Spain	5.000000	0.14
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain	3.666667	0.10
University Hospital of the Canary Islands, ULL, Spain	3.000000	0.08
Hospital Universitario Puerta de Hierro Majadahonda, UAM, Spain	3.000000	0.08
Asturias Central University Hospital (HUCA), Spain	2.000000	0.05
Autonomous University of Barcelona (UAB), Spain	1.833333	0.05
ERN RARE-LIVER, Spain, Spain	1.666667	0.05
Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Spain	1.500000	0.04
Virgen del Rocío University Hospital, Spain	1.500000	0.04
Sant Pau Research Institute (IR Sant Pau), Spain	1.000000	0.03
Bellvitge University Hospital (HUB), ICS, Spain	1.000000	0.03
Complejo Hospitalario Universitario Torrecárdenas, Spain	1.000000	0.03
University Medical Center Groningen (UMCG), RUG, Netherlands	1.000000	0.03
Vall d'Hebron Research Institute (VHIR), HUVH ICS, Spain	0.833333	0.02
Health Research Institute (IIS La Fe), Spain	0.666667	0.02
University of Valencia (UV), Spain	0.666667	0.02
Institute for Health Science Research Germans Trias i Pujol (IGTP), HUGTP ICS, Spain	0.500000	0.01
Gregorio Marañon University Hospital, Spain	0.500000	0.01

Interested in Clinical Sciences?